Patent · US Active

Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector

US9637524B2 · kind B2 · utility

0Cited by
0References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 5, 2014
Grant dateMay 2, 2017
Priority date—
Expiry dateNov 5, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2770/28142
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides a peptide/nucleic acid composition for oral/mucosal, dual-modal activation of immune protection systems.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.